Featured: Investments
Nexa Medical Team up with Novus to Exploit the Advanced Wound Care Market
The founders of Nexa Medical who have more than 50 years’ knowledge and experience of the Medical Device sector and specifically wound care, have selected Novus Investments to...
30/06/2018
Featured: Investments
Institutional Funding a Discovery for Emoquo
Emoquo, the digital coaching platform that is disrupting the mental health, corporate wellness and employee engagement markets has secured a £500,000 investment from the Discovery...
24/05/2018
Featured: Investments
Novus portfolio company Emoquo secures a £240k lift from Syndicate Room
Emoquo the innovative cloud based, digital coaching and people analytics platform has successfully closed a 240k lift round from SyndicateRoom in advance of a Series A raise later this...
01/02/2018
Featured: Investments
Novus portfolio company TC BioPharm signs US collaboration deal.
Scottish life sciences group TC BioPharm (TCB) secures a $16 million (£12 million) strategic collaboration with US bio-tech group Bluebird to discover and develop new cancer treatments.
07/12/2017
Featured: Company news
Novus Investments is delighted to be appointed an Inspire Partner
We are delighted that Novus’s unique SME business offering has been recognised and engaged by Inspire the Business Growth Network by Wessex Chambers. This now gives Inspire the...
05/12/2017
Featured: Company news
The Business Exchange raise’s Novus’s profile in Swindon & Wiltshire
With the growing popularity of The Business Exchange (Swindon & Wiltshire) for providing a fresh approach to business news and information, Novus is pleased to be working with the...
09/10/2017
Featured: Strategy
How do I build capital value in my business?
We speak to many business owners who are proud of the fact that they ‘run their own business.’ However there is often a lack of clarity between the definition of hours worked...
23/05/2017
Featured: Newsletters
Spring 2017 Newsletter
Read all the latest Novus news and case studies in the Spring 2017 issue of our newsletter, OnTrack.
23/05/2017
Featured: Investments
Novus invests in TC Biopharm as part of a £6m raise
Existing T cell therapies have had billions of dollars invested, and are based on genetically modified alpha beta cells, called CAR-T, which are complex, expensive and have significant...
10/05/2017
Featured: Company news
Novus signs joint venture with NCL Innovation to jointly market a £10m...
Ironically, most providers of capital and corporate finance advisers focus on finding solutions for larger companies, leaving early stage, high potential businesses to fend for...
10/05/2017
Featured: Investments
Making a difference to SME’s with an entrepreneurial approach to business...
To capture the combination of our investment capability, practical business knowledge and experience, we have launched our Invested Partnership model to SME’s. Essentially this...
09/05/2017